Editorial

Los trabajos y opiniones que aquí se exponen son orientadores de lo que se publica en Cuba y en el mundo sobre aspectos relevantes de la hipertensión arterial.

Editorial

Reference frame for home pulse pressure based on cardiovascular risk in 6470 subjects from 5 populations

Por: Lucas S Aparicio, Lutgarde Thijs, Kei Asayama, Jessica Barochiner, José Boggia, Yu-Mei Gu, Paula E Cuffaro1, Yan-Ping Liu, Teemu J Niiranen, Takayoshi Ohkubo, Jouni K Johansson, Masahiro Kikuya, Atsushi Hozawa8, Ichiro Tsuji, Yutaka Imai, Edgardo Sandoya, George S Stergiou, Gabriel D Waisman1 y  Jan A Staessen. Of the International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators.  Hypertension Research (2014) 37, 672–678.

The absence of an outcome-driven reference frame for self-measured pulse pressure (PP) limits its clinical applicability. In an attempt to derive an operational threshold for self-measured PP, we analyzed 6470 participants (mean age 59.3 years; 56.9% women; 22.5% on antihypertensive treatment) from 5 general population cohorts included in the International Database on HOme blood pressure in relation to Cardiovascular Outcome. During 8.3 years of follow-up (median), 294 cardiovascular deaths, 393 strokes and 336 cardiac events occurred. In 3285 younger subjects (<60 years), home PP only predicted all-cause and cardiovascular mortality (Pless than or equal to0.036), whereas in 3185 older subjects (greater than or equal to60 years) PP predicted total and cardiovascular mortality (Pless than or equal to0.0067) and all cardiovascular and coronary events (Pless than or equal to0.044).                    

 

Artículos Originales

Association between blood pressure and disability-free survival among community-dwelling elderly patients receiving  antihypertensive treatment

Revista Hypertension ResearchPor: Osamu Iritani, Yumi Koizumi, Yuko Hamazaki, Hiroshi Yano, Takuro Morita, Taroh Himeno, Tazuo Okuno, Masashi Okuro, Kunimitsu Iwai y  Shigeto Morimoto.   Hypertension Research (2014) 37, 772–778.

A reduction of elevated blood pressure (BP) is an important treatment goal in elderly hypertensive patients. However, excessive reduction of systolic BP (SBP) and/or diastolic BP (DBP) might be harmful in such patients. We investigated whether this was the case with regard to risk of incident disability or death in community-dwelling elderly subjects. Relationships among each of the four classes of SBP or DBP and the risk of incident disability or death were estimated using the Cox proportional hazards model. Over four years, 77 (13.5%) incident disabilities or deaths occurred.

Comentando

Association of Urinary Sodium and Potassium Excretion with Blood Pressure

ComentadoPor: Andrew Mente, Ph.D., Martin J. O'Donnell, M.B., Ph.D., Sumathy Rangarajan, M.Sc., Matthew J. McQueen, M.B., B.Ch., Paul Poirier, M.D., Ph.D., Andreas Wielgosz, M.D., Ph.D., Howard Morrison, Ph.D., Wei Li, Ph.D., Xingyu Wang, Ph.D., Chen Di, B.Sc., Prem Mony, M.D., Anitha Devanath, M.D., Annika Rosengren, M.D., Aytekin Oguz, M.D., Katarzyna Zatonska, M.D., Ph.D., Afzal Hussein Yusufali, M.D., P N, Et Al.  Engl J Med 2014; 371:601-611August 14, 2014DOI: 10.1056/NEJMoa1311989.

Hypertension affects 1 billion people and is considered to be a leading cause of death, stroke, myocardial infarction, congestive heart failure, and chronic renal impairment.1-4 Sodium intake is reported to be a modifiable determinant of hypertension.5,6 The International Study of Salt and Blood Pressure (INTERSALT),7 but not another large study,8 showed a modest association between higher levels of sodium intake and higher blood pressure. However, INTERSALT was not large enough to determine whether the association varied according to region, participant characteristics, or levels of sodium or potassium intake.

Factores de Riesgo

Uric acid levels predict future blood pressure and new onset hypertension in the general Japanese population

Riesgo cardiovascularPor: H. Takase, G. Kimura y Y. Dohi.  Journal of Human Hypertension (2014) 28, 529–534.

We tested the hypothesis that uric acid levels predict new-onset hypertension in the Japanese general population. Normotensive individuals who visited our hospital for a yearly health checkup (n=8157, men=61.0% and age=50.7±12.2 years) were enrolled in the present study. After baseline evaluation, participants were followed up for a median of 48.3 months (range 4.9–101.0 months), with the endpoint being the development of hypertension, defined as systolic blood pressure (BP) greater than or equal to140?mm?Hg, diastolic BP greater than or equal to90?mm?Hg or the use of antihypertensive medication.

Revisiones sistemáticas

Association between blood pressure and disability-free survival among community-dwelling elderly patients receiving  antihypertensive treatment

Revisiones sistematicasPor: Osamu Iritani, Yumi Koizumi, Yuko Hamazaki, Hiroshi Yano, Takuro Morita, Taroh Himeno, Tazuo Okuno, Masashi Okuro, Kunimitsu Iwai y  Shigeto Morimoto.   Hypertension Research (2014) 37, 772–778.

A reduction of elevated blood pressure (BP) is an important treatment goal in elderly hypertensive patients. However, excessive reduction of systolic BP (SBP) and/or diastolic BP (DBP) might be harmful in such patients. We investigated whether this was the case with regard to risk of incident disability or death in community-dwelling elderly subjects.

Investigaciones

Are There Any New Pharmacologic Therapies on the Horizon to Better Treat Hypertension?

InvestigacionesPor: Gabriel B. Habib, Sr, MS, MD, FACC, FCCP, FAHA, Sukhdeep S. Basra, MD, MPH.  J CARDIOVASC PHARMACOL THER May 1, 2014( 107).

Hypertension is the most important cardiovascular risk factor. We have witnessed a significant improvement in hypertension treatment and control and an impressive growth in the pharmacologic options available to clinicians and hypertension specialists. With up to a third of patients with hypertension not at the recommended goal blood pressures, it is critically important to develop novel therapeutic approaches to better treat hypertension.

Artículos interesantes

En esta sección les exponemos algunos artículos publicados sobre la hipertensión arterial.

Revista de Journal of Human Hypertension

Articulos interesantes

Serum uric acid and new-onset hypertension: a possible therapeutic avenue?

Por: T W Hansen, L Thijs, Y Li3,, J Boggia, Y Liu, K Asayama, M Kikuya, K Björklund-Bodegård, T Ohkubo, J Jeppesen, C Torp-Pedersen, E Dolan, T Kuznetsova, K Stolarz-Skrzypek, V Tikhonoff, S Malyutina, E Casiglia, Y Nikitin, L Lind, E Sandoya, K Kawecka-Jaszcz, J Filipovský, Y Ima, J Wang, E O'Brien y J A Staessen.Et Al .  Journal of Human Hypertension (2014) 28, 535–542.

Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populations.

Por: T W Hansen1, L Thijs, Y Li, J Boggia, Y Liu, K Asayama, M Kikuya, K Björklund-Bodegård, T Ohkubo, J Jeppesen, C Torp-Pedersen, E Dolan, T Kuznetsova, K Stolarz-Skrzypek, V Tikhonoff, S Malyutina, E Casiglia, Y Nikitin, L Lind, E Sandoya, K Kawecka-Jaszcz, J Filipovský, Y Imai, J Wang, E O'Brien y J A Staessen. Et Al.  Journal of Human Hypertension (2014) 28, 535–542.

Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions.

Por: J Peacock1, K M Diaz, A J Viera, J E Schwartz y D Shimbo.   Journal of Human Hypertension (2014) 28, 521–528

Diplomado “atención intregal al paciente hipertenso convatoria"

Diplomado “atención integral al paciente hipertenso convatroria".

La Comisión Nacional Técnica Asesora del programa de hipertensión arterial del Ministerio de Salud Pública y el “Hospital Clínico Quirúrgico “Hermanos Ameijeiras”, convocan al Diplomado de “Atención integral al paciente hipertenso” , cuyo objetivo principal es contribuir a elevar el conocimiento en el desempeño de la atención a los pacientes con hipertensión arterial.

Podrán optar por este Diplomado los Médicos Especialistas en: Medicina General Integral, Medicina Interna, Cardiología, Pediatría, Geriatría, Nefrología, Endocrinología y de otras especialidades clínicas, vinculadas a la asistencia del pacientes hipertensos y que se desempeñen principalmente en la atención primaria de salud. El Diplomado es semipresencial y la actividad académica será un día por semana. Duración 35 semanas.

La sede principal será el Hospital “Hnos. Ameijeiras” y las otras sedes, serán el Instituto de Cardiología, Instituto de Nefrología, el Hospital Calixto García y el Hospital Pediátrico de Centro Habana. Fecha de comienzo, 2da quincena de Septiembre de 2014

La solicitud de inscripción se deberá dirigir por correo electrónico a perezcaballero@hha.sld,cu. Se recibirán por esta vía hasta el día 10 de septiembre/14.

En la solicitud deberá consignarse:

1. Nombre y apellidos,

2. Especialidad,

3. Año de graduado,

4. Centro de trabajo y cargo o labor que desempeña (Jefe de G. básico, médico asistencial, responsable docente, etc)

Dado que la matrícula del Diplomado es limitada, el Comité Académico, seleccionará los cursistas y se les comunicará oportunamente, ya que una vez aceptado deberán tener la autorización del servicio o centro de trabajo para garantizar la asistencia, un día a la semana, según programación del Diplomado

Por la Comisión Nacional de Hipertensión arterial Asesora del MINSAP

DrC. Manuel Delfín Pérez Caballero